Chromocell Therapeutics Corp
AMEX:CHRO
Income Statement
Earnings Waterfall
Chromocell Therapeutics Corp
Income Statement
Chromocell Therapeutics Corp
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(7)
|
(8)
|
(8)
|
(6)
|
(5)
|
|
| Selling, General & Administrative |
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(3)
|
(1)
|
(1)
|
|
| Operating Income |
(1)
N/A
|
(2)
-87%
|
(2)
-27%
|
(3)
-27%
|
(3)
-16%
|
(4)
-7%
|
(7)
-86%
|
(8)
-15%
|
(8)
+0%
|
(6)
+26%
|
(5)
+8%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(2)
-86%
|
(2)
-27%
|
(3)
-27%
|
(4)
-20%
|
(4)
-9%
|
(7)
-81%
|
(9)
-22%
|
(8)
+8%
|
(6)
+25%
|
(6)
+10%
|
|
| Net Income | ||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(7)
|
(9)
|
(8)
|
(6)
|
(6)
|
|
| Net Income (Common) |
(1)
N/A
|
(2)
-86%
|
(2)
-27%
|
(3)
-27%
|
(4)
-20%
|
(4)
-9%
|
(7)
-81%
|
(9)
-22%
|
(8)
+8%
|
(6)
+25%
|
(6)
+10%
|
|
| EPS (Diluted) |
-0.18
N/A
|
-0.34
-89%
|
-0.43
-26%
|
-0.55
-28%
|
-0.66
-20%
|
-0.72
-9%
|
-1.28
-78%
|
-1.91
-49%
|
-1.43
+25%
|
-1.02
+29%
|
-0.91
+11%
|
|